Why is Essity stock sliding today?

Essity AB Class A fell 1.1% to trade at 272 SEK during today’s session after UBS downgraded the Swedish hygiene and health company to a Sell rating and set a price target of SEK 235, a level significantly below where the stock had been trading in recent days.

The deeply bearish call from the U.S. bank rattled investors and drove a wave of selling pressure that pushed shares from their opening level of 273.5 SEK to a session low of 271 SEK.

The downgrade arrives against a backdrop of already softening fundamentals: Essity’s most recently reported quarter showed EBITA contracting by 11% and net income declining 12% year-over-year, results that had already prompted several other analysts to trim their price targets in prior months.

The stock’s current level of 272 SEK sits well below its 52-week high of 292.5 SEK, reflecting the cumulative weight of margin concerns and a challenging input cost environment that management has flagged as an ongoing headwind.

From a broader market perspective, the OMXS30 — Sweden’s benchmark large-cap index — was actually trading modestly higher on the day, partially clawing back losses from a difficult prior session when the index fell 0.6%. Essity’s decline therefore stood in contrast to the general market tone, reinforcing that today’s move is company-specific rather than a reflection of macro or sector-wide selling.

U.S. equity benchmarks were also little changed, providing no additional directional push.

Taken together, the UBS downgrade served as the single clearest catalyst for today’s pullback, amplifying existing concerns about Essity’s near-term earnings trajectory and margin recovery. With the stock now trading closer to the lower end of its 52-week range of 237–292.5 SEK, investors appear to be reassessing whether the current valuation adequately prices in the risks highlighted by the bank’s bearish thesis.